Applications for the 2021 Fellowship are no longer being accepted.
What is the purpose of this Fellowship?
The ASTRO-AstraZeneca Radiation Oncology Research Training Fellowship is a joint effort to provide physician-scientists with real-world experience in late-stage clinical trial development at the facilities of AstraZeneca and its Affiliates.
The fellow is anticipated to remain an affiliate of the fellow’s home institution (“Institution”) but receive research training at an AstraZeneca corporate site through conducting research project(s) under the development by and supervision of AstraZeneca.
The fellow can expect to work with AstraZeneca to focus on drug development challenges in late-stage drug-radiation combination, drug sequences, Immuno-Oncology (“IO”) or Epidermal growth factor receptor (“EGFR”). All work will be conducted at an AstraZeneca research site and not at the fellow’s home Institution or any other academic site.
Before embarking on the fellowship, the fellow and the fellow’s home Institution will be required to sign a Research Agreement with AstraZeneca that includes intellectual property arrangements and a separate agreement with ASTRO to cover the terms and conditions of the Fellowship.
When does the fellowship begin?
The anticipated start date for the 2021 Fellowship is July 1, 2021. The actual start date is dependent on the fellow and the fellow's home Institution establishing relevant agreements with AstraZeneca and ASTRO.
$100,000 is anticipated to be awarded to the selected fellow’s home Institution. The fellowship funds must be used for salary support for the selected fellow and a fraction of the funds can be used for travel to the ASTRO Annual Meeting. Neither ASTRO nor AstraZeneca will pay indirect costs as part of this award. No funds may be used for laboratory or other supplies.
- As of the application due date, the applicant must hold a doctorate degree such as PhD, MD/PhD, MD, DO or other equivalent degree(s).
- As of the application due date, the individual applicant must be currently matriculated in an accredited residency program operated by the applicant’s current training organization (i.e., the Institution) in the United States (U.S.) and have sufficient time (1 year) to conduct a research project at AstraZeneca starting July 1, 2021.
- Faculty members or equivalent status are not eligible to apply.
- The applicant must be a citizen or a noncitizen national of the U.S. or have been lawfully admitted for permanent residence by the time of award.
- The applicant must be a current and active ASTRO member, or have submitted an application for ASTRO membership, as of the due date of the fellowship application.
How do I apply?
Applications must be submitted online at ProposalCentral. Applications were due on January 8, 2021,11:59 p.m. ET (GMT-5).
For more information please contact the Department of Scientific Affairs.